Article

The 3-layered Ductal Epithelium in Gynecomastia

Department of Pathology, University Medical Center Utrecht, The Netherlands.
The American journal of surgical pathology (Impact Factor: 4.59). 02/2012; 36(5):762-8. DOI: 10.1097/PAS.0b013e31824324e6
Source: PubMed

ABSTRACT Gynecomastia is the most common abnormality in the male breast and has been associated with male breast cancer, but whether there is an etiological role remains unknown. In the present study we conducted an immunohistochemical investigation to further characterize gynecomastia. A total of 46 cases of gynecomastia were immunohistochemically stained on tissue microarrays for estrogen receptor (ER), progesterone receptor, HER2, androgen receptor, cytokeratins (CK5, CK14, CK7, and CK8/18), p63, E-cadherin, BRST2, cyclin D1, Bcl-2, p53, p16, p21, and Ki67. In addition, 8 cases of male ductal carcinoma in situ and normal breast tissue obtained from autopsies (n=10) and adjacent to male breast cancer (n=5) were studied. Normal ductal male breast epithelial cells were very often ER and Bcl-2 positive (>69%), and progesterone receptor and androgen receptor expression was also common (>39%). Gynecomastia showed a consistent 3-layered pattern: 1 myoepithelial and 2 epithelial cell layers with a distinctive immunohistochemical staining pattern. The intermediate luminal layer, consisting of vertically oriented cuboidal-to-columnar cells, is hormone receptor positive and expresses Bcl-2 and cyclin D1. The inner luminal layer is composed of smaller cells expressing CK5 and often CK14 but is usually negative for hormone receptors and Bcl-2. Male ductal carcinoma in situ was consistently ER positive and CK5/CK14 negative. In conclusion, for the first time we describe the 3-layered ductal epithelium in gynecomastia, which has a distinctive immunohistochemical profile. These results indicate that different cellular compartments exist in gynecomastia, and therefore gynecomastia does not seem to be an obligate precursor lesion of male breast cancer.

0 Followers
 · 
106 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Gynaecomastia (enlargement of the male breast tissue) is a common finding in the general population. Most cases of gynaecomastia are benign and of cosmetic, rather than clinical, importance. However, the condition might cause local pain and tenderness, could occasionally be the result of a serious underlying illness or a medication, or be inherited. Breast cancer in men is much less common than benign gynaecomastia, and the two conditions can usually be distinguished by a careful physical examination. Estrogens are known to stimulate the growth of breast tissue, whereas androgens inhibit it; most cases of gynaecomastia result from deficient androgen action or excessive estrogen action in the breast tissue. In some cases, such as pubertal gynaecomastia, the breast enlargement resolves spontaneously. In other situations, more active treatment might be required to correct an underlying condition (such as hyperthyroidism or a benign Leydig cell tumour of the testis) or medications that could cause breast enlargement (such as spironolactone) might need to be discontinued. For men with hypogonadism, administration of androgens might be helpful, as might antiestrogen therapy in men with endogenous overproduction of estrogens. Surgery to remove the enlarged breast tissue might be necessary when gynaecomastia does not resolve spontaneously or with medical therapy.
    Nature Reviews Endocrinology 08/2014; 10(11). DOI:10.1038/nrendo.2014.139 · 12.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In females, columnar cell lesions (CCLs) have been recognized as putative precursor lesions of low grade nuclear breast cancer, but their role in male breast carcinogenesis is yet unclear. We reviewed surgical resections from males with breast cancer (N=89), gynaecomastia (N=20) and normal breast specimens from autopsies (N=5) for the presence of CCL. In addition, we performed immunohistochemistry for cytokeratin (CK) 5/6, CK14 and estrogen receptor alpha (ER). In 19 of 89 resections (2 DCIS cases and 17 invasive carcinoma), some individual ducts were found with cells with snouts on the luminal border but lacking further typical columnar cell lesion features. We mostly found three layered ductal epithelium characteristic for gynaecomastia, confirmed by immunohistochemistry. Moreover, we found a few ducts in male breast cancer slides that were clonally negative for basal cytokeratins. We found no lesions with convincing CCL morphology in the periphery of invasive male breast cancer as well as in gynaecomastia or normal male breast specimens. Even though we cannot completely exclude the existence of CCLs in the male breast, at least these lesions seem to be very uncommon and are therefore unlikely to play a major role in male breast carcinogenesis. This article is protected by copyright. All rights reserved.
    Histopathology 11/2013; DOI:10.1111/his.12333 · 3.30 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: AimsSyringomatous tumour of the nipple and low-grade adenosquamous carcinoma (LGAdSC) of the breast are regarded as distinct entities. To clear the nature of these two lesions, we compared the expression of different lineage/differentiation markers in 12 syringomatous tumours of the nipple, 9 LGAdSC, and normal breast epithelium. Methods and resultsUsing triple immunofluorescence labelling and quantitative RT-PCR studies for keratins, p63 and SMA, we demonstrated that syringomatous tumour and LGAdSC contain p63+/K5/K14+ tumour cells, K10+ squamous, and K8/18+ glandular cells with intermediary cells in both lineages. Identical p63+/K5/14+ cells were also found in the normal breast duct epithelium. Conclusions Our data provide evidence that syringomatous tumour of the nipple and LGAdSC are identical or nearly identical lesions. They contain p63+/K5/K14+ cells as the key cells from which K10+ squamous and K8/18+ glandular lineage arise. Based on our findings in normal breast tissue and associated benign lesions, we suggest that p63+/K5/14+ cells of the normal breast duct epithelium or early related cells might play a key role in neoplastic transformation of both syringomatous tumour and LGAdSC. We propose that the differentiation patterns found in both lesions reflect the early ontogenetic stages of the normal breast epithelium.This article is protected by copyright. All rights reserved.
    Histopathology 07/2014; 65(1). DOI:10.1111/his.12358 · 3.30 Impact Factor